Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

NCT00116142 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Docetaxel
DRUG: Androgen Hormonal Suppression and Radiation
DRUG: Androgen Suppression Therapy and Radiation Therapy

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]